doi: 10.1016/j.metabol.2019.154011 136 ZhouDPanQXinFZZhangRNHeCXChenGYet al
Slowing the ramp to the label cadence (2.5 mg start, 2.5 mg steps, four-week holds) dropped that to mid-single digits at every maintenance dose, at no cost to the 12-week result, and the dedicated slow-titration trial reached placebo range. Reaching 15 mg is not the problem
While Clomiphene can increase testosterone, it should be noted that its use is not free of concerns
Carmot Therapeutics is now expanding the trials to include overweight and obese patients with type 2 diabetes, to assess further CT-868s impact on glycemic control, weight loss, and tolerability
Hyperinsulinemia: A Product Caused by PDA Unlike other cancer, a unique phenomenon is that PDA actively induces hyperglycemia or even diabetes through inducing peripheral insulin resistance as early as the PanIN (a precursor of pancreatic cancer) period
All study participants gave written informed consent and were informed about the study (EK Nr: 1023/2024)